Avraham Gabay
Chief Financial Officer · ORAMED PHARMACEUTICALS INC.
- 2024
- Oct 2, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Avraham Gabay files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joshua Hexter - $747K in ORMP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Avraham Gabay?
Avraham Gabay is a corporate insider, tracked as Chief Financial Officer of ORAMED PHARMACEUTICALS INC. (ORMP). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Avraham Gabay submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Avraham Gabay been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($421K) across all tracked filings.
